Skip to main content
SpringerLink
Log in

Informed consent and the use of placebo in poland: Ethical and legal aspects

  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

Abstract

The concept of informed consent was one of the most fruitful ideas that deeply changed the relationships between physicians and their patients from paternalism to respect for the personal autonomy of subjects needing professional medical care. The great progress in medicine, also involving the pharmaceutical industry, has created an increasing need to perform different clinical and experimental trials. The evolution of clinical research in the last decades has influenced strongly the design of these studies. One of the most important changes in this field has been the use of placebo groups in double-blind controlled studies. The controversies have involved not only the use of placebo when standard or proven treatment was available, but also some specific problems concerning the procedure of obtaining informed consent in such trials. This paper briefly presents the evolution of informed consent in Poland as well as different ethical and legal problems concerning informed consent and the use of placebo controls in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miller F.G., Shorr F. (2002) Ethical Assessment of Industry-Sponsored Clinical Trials: A Case Analysis. Chest 121(4): 1337–1342.

    Article  Google Scholar 

  2. Djulbegovic B., Lacevic M., Cantor A., Fields K.K., Bennett C.L., Adams J.R., Kuderer N.M., Lyman G.H. (2000) The uncertainty principle and industry-sponsored research Lancet 356(9230): 635–638.

    Article  Google Scholar 

  3. Shapiro H.T. & Meslin E.M. (2001) Ethical Issues in the Design And Conduct of Clinical Trials in Developing Countries NEJM 345(2): 139–142.

    Article  Google Scholar 

  4. Nesterowicz M. (1998) Prawo medyczne (Medical Law), Torun, p. 109.

  5. Sosniak M. (1977) Cywilna odpowiedzialnosc lekarza (Civil responsibility of physicians), Warszawa, p. 69.

  6. Critical approach by B. Wertheim: Kilka uwag o odpowiedzialnosci cywilnej lekarzy (Several remarks on civil responsibility of physicians) Palestra 1936, No 4–5.

  7. Dz. U. (Journal of Laws) 1997, no. 28, pos. 28.

  8. Beauchamp R.L. & Childress J.F. (1995) Encyclopedia of Bioethics, pp. 215–20.

  9. Kagarise M.J. & Sheldon G. (2000) Translational Ethics: A Perspective for the New Millennium Arch Surg 135: 39–45.

    Article  Google Scholar 

  10. Miyaji N.T. (1993) The power of compassion: truth-telling among American doctors in the care of dying patients. Social Science & Med. 36(3): 249–64.

    Article  Google Scholar 

  11. Weston B. & Lauria M. (1996) Patient Advocacy in the 1990s NEJM 334(8): 543–544.

    Article  Google Scholar 

  12. Zoll A. (1996) Uswiadomiona zgoda (Informed consent). Zeszyty PAU 5: 9–18.

    Google Scholar 

  13. Syse A. (2000) Norway: valid (as opposed to informed) consent. Lancet 356(9238): 1347–1348.

    Article  Google Scholar 

  14. Mulcahy D., Cunningham K., McCormack D., Cassidy N. & Walsh M. (1997) Informed consent from whom? J.Roy.Coll.Surg.Edinburgh. 42(3): 161–4.

    Google Scholar 

  15. Lembcke B., Specht J., Nippel G. & Caspary W.F. (1998) Structure and quality of German-language gastroscopy information forms from the patients’ viewpoint. Zeitschrift fur Gastroenterologie. 36(9): 829–38.

    Google Scholar 

  16. Kirsch M. (2000) The myth of informed consent. Am. J. Gastroenterol. 95(3): 588–9.

    Article  Google Scholar 

  17. Oxman A., Chalmers I & Sackett DL. (2001) A practical guide to informed consent to treatment. BMJ 323(7327): 1464–1466

    Article  Google Scholar 

  18. Emanuel E.J., Wendler D. & Grady C. (2000) What Makes Clinical Research Ethical? JAMA 283: 2701–2711.

    Article  Google Scholar 

  19. Vanderpool HY. (1996) The Ethics of Research Involving Human Subjects. Frederick, Md: University Publishing Group, pp. 45–58.

    Google Scholar 

  20. Levine R.J. (1988) Ethics and Regulation of Clinical Research. 2nd ed. New Haven, Conn: Yale University Press; 1988

    Google Scholar 

  21. Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: CIOMS; 2002.

    Google Scholar 

  22. Partridge A.H., Winer E.P. (2002) Informing Clinical Trial Participants About Study Results. JAMA 288(3): 363–365.

    Article  Google Scholar 

  23. Rothmann K..J & Michels K.B. (1994) The Continuing Unethical Use Of Placebo Controls. NEJM 331(6): 394–398.

    Article  Google Scholar 

  24. Editorial (2002) The better-than-nothing idea: debating the use of placebo controls CMAJ 166(5): 573.

    Google Scholar 

  25. Temple R.J. & Meyer Robert (2003) Continued Need for Placebo in Many Cases: Even When There Is Effective Therapy Arch.Int.Med. 163(3): 371–372.

    Article  Google Scholar 

  26. Temple R. & Ellenberg S.S. (2000) Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments: Part 1: Ethical and Scientific Issues Ann.Int.Med. 133(6): 455–463.

    Google Scholar 

  27. Ellenberg S.S. & Temple R. (2000) Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments: Part 2: Practical Issues and Specific Cases Ann.Int.Med. 133(6): 464–470.

    Google Scholar 

  28. Miller FG. & Shorr AF. (2002) Unnecessary Use of Placebo Controls: The Case of Asthma Clinical Trials Arch.Int.Med. 162(15): 1673–1677

    Article  Google Scholar 

  29. World Medical Association. (2002). Revised Declaration of Helsinki: ethical principles for medical research involving human subjects. (with Note of clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002). Available at: http://www.wma.net/policy/b3.htm. Accessed: October 2003

  30. Freedman B., Weijer C. & Glass K.C. (1996) Placebo orthodoxy in clinical research: Empirical and methodological myths. J Law Med Ethics 24(3): 243–51.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Zoonoses and Parasitic Diseases, Medical University of Warsaw, Wolska str. 37, 01-201, Warsaw, Poland

    Piotr Zaborowski MD

  2. University of Białystok, Poland

    Adam Górski

Authors
  1. Piotr Zaborowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam Górski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Piotr Zaborowski MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaborowski, P., Górski, A. Informed consent and the use of placebo in poland: Ethical and legal aspects. SCI ENG ETHICS 10, 167–178 (2004). https://doi.org/10.1007/s11948-004-0074-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-004-0074-9

Keywords

Search

Navigation